Permeability Assessment of a High-Throughput Mucosal Platform.
3R
PermeaPad
drugs
mucus
permeability
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
22 Jan 2023
22 Jan 2023
Historique:
received:
16
12
2022
revised:
17
01
2023
accepted:
18
01
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Permeability across cellular membranes is a key factor that influences absorption and distribution. Before absorption, many drugs must pass through the mucus barrier that covers all the wet surfaces of the human body. Cell-free in vitro tools currently used to evaluate permeability fail to effectively model the complexity of mucosal barriers. Here, we present an in vitro mucosal platform as a possible strategy for assessing permeability in a high-throughput setup. The PermeaPad 96-well plate was used as a permeability system and further coupled to a pathological, tridimensional mucus model. The physicochemical determinants predicting passive diffusion were determined by combining experimental and computational approaches. Drug solubility, size, and shape were found to be the critical properties governing permeability, while the charge of the drug was found to be influential on the interaction with mucus. Overall, the proposed mucosal platform could be a promising in vitro tool to model the complexity of mucosal tissues and could therefore be adopted for drug-permeability profiling.
Identifiants
pubmed: 36839702
pii: pharmaceutics15020380
doi: 10.3390/pharmaceutics15020380
pmc: PMC9966667
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondo Integrativo Speciale per la Ricerca (FISR)
ID : FISR2020-02115 - "Mucus4COVID: a prototype providing in vitro 3D-model to determine the role of pulmonary mucus on Sars-Cov2 infection, transmission and discover efficient therapies to block disease progression"
Organisme : University of Turin
ID : Ricerca Locale ex-60%, Linea A, Bando 2020
Références
Pharm Res. 2008 Jul;25(7):1511-20
pubmed: 18185985
J Pharmacol Toxicol Methods. 2009 Jan-Feb;59(1):39-43
pubmed: 19049886
J Pharm Sci. 2008 Feb;97(2):712-25
pubmed: 17542022
Eur J Pharm Sci. 2018 Jul 1;119:219-233
pubmed: 29660464
Pharmaceutics. 2020 Feb 17;12(2):
pubmed: 32079348
Pharm Res. 2020 May 11;37(6):93
pubmed: 32394114
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D668-72
pubmed: 16381955
Biochim Biophys Acta. 2016 Oct;1858(10):2254-2265
pubmed: 27085977
Semin Respir Crit Care Med. 2019 Dec;40(6):804-809
pubmed: 31659729
Mol Pharm. 2021 Jun 7;18(6):2122-2141
pubmed: 33914545
Pharmaceutics. 2018 Dec 06;10(4):
pubmed: 30563197
J Intern Med. 2019 May;285(5):479-490
pubmed: 30963635
Gastroenterology. 1989 Mar;96(3):736-49
pubmed: 2914637
Nat Rev Drug Discov. 2010 Aug;9(8):597-614
pubmed: 20671764
Pharmaceutics. 2022 Mar 28;14(4):
pubmed: 35456555
ACS Biomater Sci Eng. 2019 Mar 11;5(3):1189-1194
pubmed: 33405639
Int J Pharm. 2013 Aug 30;453(1):56-64
pubmed: 23727593
Mol Pharm. 2022 Feb 7;19(2):520-531
pubmed: 34936359
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):27-43
pubmed: 11259831
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Int J Pharm. 2017 Oct 30;532(1):555-572
pubmed: 28917986
Int J Pharm. 2019 Jun 10;564:136-144
pubmed: 30991132
Chest. 2018 Jul;154(1):169-176
pubmed: 29170036
Adv Drug Deliv Rev. 2022 Dec;191:114540
pubmed: 36228896
J Mater Chem B. 2019 Aug 14;7(32):4940-4952
pubmed: 31411620
Nucleic Acids Res. 2021 Jul 2;49(W1):W5-W14
pubmed: 33893803
Clin Rev Allergy Immunol. 2008 Apr;34(2):146-62
pubmed: 17960347
J Med Chem. 1998 Mar 26;41(7):1007-10
pubmed: 9544199
Curr Drug Metab. 2008 Nov;9(9):893-900
pubmed: 18991586
Antimicrob Agents Chemother. 2015 Oct;59(10):5925-31
pubmed: 26169405
Int J Pharm. 2020 Mar 15;577:119009
pubmed: 31917299
Eur J Pharm Sci. 2008 Dec 18;35(5):383-96
pubmed: 18782614
Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):179-86
pubmed: 25349046
J Pharm Sci. 1999 Jan;88(1):28-33
pubmed: 9874698
Pharm Res. 2011 May;28(5):962-77
pubmed: 21052797
Antimicrob Agents Chemother. 1995 Jan;39(1):34-9
pubmed: 7535039